Hangzhou Tigermed Consulting Co., Ltd
300347
Xếp hạng trong cổ phiếu
#3217
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides... Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
Giá cổ phiếu
$7.44
Vốn hóa thị trường
$5.49B
Thay đổi (1 ngày)
-2.99%
Thay đổi (1 năm)
-0.42%
Quốc gia
CN
Giao dịch Hangzhou Tigermed Consulting Co., Ltd (300347)
Danh mục
Healthcare
Lịch sử cổ tức của Hangzhou Tigermed Consulting Co., Ltd (300347)
Hangzhou Tigermed Consulting Co., Ltd (mã cổ phiếu: 300347) đã thực hiện tổng cộng 14 lần chi trả cổ tức.
Tổng tất cả cổ tức (đã điều chỉnh theo chia tách cổ phiếu): $3.46
Tỷ suất cổ tức (TTM): 0.0025
Tổng tất cả cổ tức (đã điều chỉnh theo chia tách cổ phiếu): $3.46
Tỷ suất cổ tức (TTM): 0.0025
Các khoản chi trả cổ tức của Hangzhou Tigermed Consulting Co., Ltd (300347) từ 2013 đến 2026
Các khoản chi trả cổ tức hàng năm
| Năm | Cổ tức (đã điều chỉnh chia tách cổ phiếu) | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.126 | -58.00% |
| 2025 | $0.3 | -47.18% |
| 2024 | $0.568 | 3.27% |
| 2023 | $0.55 | 10.00% |
| 2022 | $0.5 | 66.67% |
| 2021 | $0.3 | 7.91% |
| 2020 | $0.278 | 19.16% |
| 2019 | $0.2333 | 75.02% |
| 2018 | $0.1333 | 99.85% |
| 2017 | $0.0667 | 0.00% |
| 2016 | $0.0667 | -49.96% |
| 2015 | $0.1333 | 0.00% |
| 2014 | $0.1333 | 99.85% |
| 2013 | $0.0667 | 0.00% |
Danh sách tất cả các khoản chi trả cổ tức
| Năm | Cổ tức | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.126 | -58.00% |
| 2025 | $0.3 | -47.18% |
| 2024 | $0.568 | 3.27% |
| 2023 | $0.55 | 10.00% |
| 2022 | $0.5 | 66.67% |
| 2021 | $0.3 | 7.91% |
| 2020 | $0.278 | -20.57% |
| 2019 | $0.35 | 75.00% |
| 2018 | $0.2 | 100.00% |
| 2017 | $0.1 | 0.00% |
| 2016 | $0.1 | -75.00% |
| 2015 | $0.4 | -50.00% |
| 2014 | $0.8 | 0.00% |
| 2013 | $0.8 | 0.00% |
Cổ tức của các công ty tương tự hoặc đối thủ
| Công ty | Số lần chi trả cổ tức | Quốc gia |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
